|
|
||||||||
1 From the Departments of Human Biological Chemistry and Genetics and 2 Physiology and Biophysics, University of Texas Medical Branch, Galveston, Texas; and the 3 Division of Cardiology, Department of Medicine, University of Louisville, Louisville, Kentucky.
| Abstract |
|---|
|
|
|---|
METHODS. Fiber cells from rat lens cortex were isolated, and the [Ca2+]i and protease activity in the isolated fibers were determined by using a calcium binding dye and the protease substrate t-butoxycarbonyl-Leu-Met-7-amino-4-chloromethylcoumarin (BOC-Leu-Met-CMAC). The activity of calpain in the lens cortex homogenate was determined with fluorescein-casein in the presence of Ca2+ and that of fiber cell globulizing aminopeptidase (FCGAP) with BOC-Leu-Met-CMAC and reduced glutathione (GSH) in the absence of Ca2+. The lens proteases-calpain and the novel aminopeptidase FCGAP were partially purified by diethylaminoethyl (DEAE) gel column chromatography. Single fiber cells were isolated from rat lens, plated on coverslips, and placed in a temperature-controlled chamber. Their globulization time was determined by the appearance of light-scattering globules in the absence and the presence of protease inhibitors including the aminopeptidase inhibitor bestatin. To investigate the effect of the protease inhibitors E-64 and bestatin on the prevention of hyperglycemic cataract, the rat lenses were cultured in medium 199 in the presence of 5.5 and 50 mM glucose and in the absence and the presence of protease inhibitors. Changes in light transmission by the lenses were determined by digital image analysis.
RESULTS. Normal levels of lens fiber cell [Ca2+]i, determined by using a cell-permeable dye were approximately 100 nM, and the protease activity determined with BOC-Leu-Met-CMAC was maximum at [Ca2+]i of approximately 500 nM. A large fraction of the FCGAP that cleaves BOC-Leu-Met-CMAC was separated from calpain, which cleaves fluorescein-casein, by diethylaminoethyl (DEAE) gel column chromatography. The FCGAP did not bind to the column, whereas calpain bound to the column and was eluted by approximately 180 mM NaCl. Unlike calpain, the FCGAP did not require calcium for activation and did not cleave fluorescein-casein. However, the Ca2+-dependent calpain activated FCGAP, indicating that the latter may exist in pro-protease form. The FCGAP was selectively inhibited by the specific aminopeptidase inhibitor bestatin, indicating that FCGAP could be an aminopeptidase. However, the FCGAP was found to be immunologically distinct from leucine aminopeptidase and calpain. Perfusion of the isolated rat lens fiber cells with Ringers solution led to their globulization in 30 ± 3 minutes. Addition of 0.5 mM of the protease inhibitors E-64 and leupeptin increased the globulization time to 60 and 100 minutes, respectively, whereas no globulization of the fiber cells was observed for 4 hours in the presence of 0.05 mM bestatin. In rat lens cultured in medium containing 50 mM glucose, both E-64 and bestatin (0.05 mM each) significantly reduced the extent of opacification, indicating that an aminopeptidase, downstream to a Ca2+-dependent protease, may be involved in mediating cataractogenic changes.
CONCLUSIONS. In addition to calpain, a Ca2+-independent novel protease, FCGAP, a novel aminopeptidase, represents a significant fraction of the total proteolytic activity in the lens. Inhibition of FCGAP by bestatin attenuates Ca2+-induced globulization of the isolated fiber cells in vitro and hyperglycemia-induced opacification of cultured rat lens.
| Introduction |
|---|
|
|
|---|
We have shown that, in isolated fiber cells, the [Ca2+]i is approximately 100 nM.5 This is in contrast to earlier reports10 11 that indicate that [Ca2+]i in fiber cells may be as high as 1 to 2 mM, when measured by atomic absorption techniques and 1 to 2 µM when measured by Ca2+-selective electrodes. However, we observed that exposure to normal Ringers solution increases [Ca2+]i, which is accompanied by an increase in the protease activity in isolated fiber cells, as determined by using a fluorescent substrate, t-butoxycarbonyl-Leu-Met-7-amino-4-chloromethylcoumarin (BOC-Leu-Met-CMAC).8 The maximum increase in protease activity is observed when the [Ca2+]i of the fiber cells is less than 0.5 µM, and most of the fiber cells globulize before the [Ca2+]i reaches the level of 1.0 to 1.5 µM.8
The proteases calpains I and II have been implicated in cataractogenesis by a number of investigators.12 13 Based on in vitro studies with purified enzymes, it has been shown that calpain I requires at least 10 µM [Ca2+]i for maximal activation, whereas calpain II is maximally activated by 1 to 2 mM calcium. Because lens fiber cells start globulizing when [Ca2+]i is less than 0.5 µM,8 it is likely that protease(s) other than calpain may also be involved in fiber cell globulization and possibly in supranuclear cataractogenesis. Because our initial studies indicated that the protease activity of the isolated lens fiber cells, determined with the fluorescent substrate BOC-Leu-Met-CMAC, is maximally activated in the presence of low (<0.5 µM) [Ca2+]i, we partially purified the proteases from the rat lens cortex, using the method of David and Shearer14 for the isolation of calpain. Our results indicate that calpain and the novel protease, which we refer to as FCGAP, completely separate from each other in diethylaminoethyl (DEAE) gel column chromatography. The FCGAP did not bind to the column, whereas calpain was retained in the column and was eluted by approximately 180 mM NaCl, as described by David and Shearer. The FCGAP was inhibited by bestatin, an aminopeptidase inhibitor,15 16 whereas this inhibitor had no significant effect on calpain activity. In the current study, bestatin significantly delayed the globulization of isolated rat lens fiber cells, superfused with Ringers solution containing 2 x 10-3 M Ca2+, and also prevented hyperglycemia-induced opacification of cultured rat lenses.
| Materials and Methods |
|---|
|
|
|---|
Isolation of Fiber Cells and Determination of Globulization Time, Protease Activity, and [Ca2+]i
SpragueDawley rats (each weighing 200250 g) were housed in accordance with the institutional guidelines and were killed by a single intraperitoneal injection of pentobarbital sodium. All animals were treated according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The globes were removed and immersed in Ringers solution. The lenses were dissected with the capsule intact. Single fiber cells were isolated with trypsin and a temperature gradient, as described elsewhere.3
4
5
6
7
8
Freshly isolated fiber cells, (2.02.5 mm in length) were allowed to attach to a coverslip and incubated with 0.5 mL of the indicated solutions. To determine the effect of bestatin, the fiber cells were incubated with Ringers solution containing 2.0 x 10-3 M Ca2+, with or without 0.05 mM bestatin. Changes in fiber cell morphology were observed with an inverted microscope (Diaphot 300; Nikon, Tokyo, Japan). Tg refers to the time required for complete fiber cell globulization.
Determination of [Ca2+]i
The [Ca2+]i measurements in isolated fiber cells were performed using a calcium-binding dye (Fluo-3 AM; Molecular Probes). The calibration procedure was essentially the same as described previously.5
Briefly, the fibers were incubated with 10 µM of the dye for 3 hours at 37°C in HEPES-EDTA-sucrose (HES) solution (composition in millimolar: sucrose 280, Na-EDTA 10, HEPES 10 [pH 7.4], 300310 mOsm). After incubation, the fibers were layered on the coverslip at the bottom of the tissue chamber. Fluorescence (F) of the fiber cell was measured at excitation wavelength 490 nm, and emission wavelength 520 nm. Maximum fluorescence (Fmax) was determined by the addition of ionophore A23187 (10 µM), and the minimum (Fmin) was determined by measuring the fluorescence after quenching by the addition of MnCl2 (2.0 mM). The [Ca2+]i was calculated by the following equation
![]() |
Determination of Intracellular Protease Activity in a Single Fiber Cell
Protease activity of individual fiber cells was determined by incubating the cells with the protease substrate BOC-Leu-Met-CMAC. This substrate readily permeates biological membranes and, once inside the cell, conjugates with GSH to form BOC-Leu-Met-CMAC-SG.17
Proteases cleave the conjugate between methionine and CMAC-SG, resulting in the fluorescent product CMAC-SG, which has an emission maxima at 410 nm when excited at 360 nm.
BOC-Leu-Met-CMAC was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution of 4.5 mM. The final working concentration used was 10 µM. The fibers were preincubated for 5 minutes in 0.5 mL of HES solution containing 10 µM substrate and then transferred to a circular tissue chamber, which had 3 mL of solution containing 10 µM substrate. The fluorescence of a single fiber was measured with a microfluorimeter, built around an inverted microscope (Diaphot 300; Nikon) that was equipped with an epifluorescence attachment and two photomultiplier tubes (PMTs).5 The fiber cell was plated on a coverslip attached to the bottom of the circular tissue chamber. The fibers were illuminated with a 150-W xenon lamp, powered by a constant current power supply (Universal Power Supply, model 68805; Oriel, Stratford, CT).
The light from the lamp was collimated through a beam probe and delivered to the filter assembly through a dichroic mirror installed in the microscope. The fiber cell was illuminated with excitation light at 360 nm and the emission fluorescence was measured at 410 nm using a long pass filter. The fluorescence from the fiber cell was collected through a 20x objective lens (CF Fluor; Nikon), and conducted through the side port of the microscope. To minimize collection of stray light, a rectangular shutter (model 85291; Nikon) was used to mask the portion of the image not occupied by the fiber cell. The masking cube was connected to a viewer (PFX; Nikon) for alignment and optical viewing of the fiber cell. The PMTs (HC 124-03; Hamamatsu, Hamamatsu City, Japan) were connected to the microscope through a beam splitter holder. The PMTs were energized using a 12-V power supply (LPS 11; Leader Electronic Corp., Cypress, CA). The gain of the PMT was set by adjusting the voltage on the analog-to-digital conversion board to be between 500 and 900 V. The setup was used in single-photoncounting mode, and the data were acquired by a set of concatenated counters (TIP-10), using a computer program (LabView; National Instruments, Austin, TX). The microfluorimeter was placed on a vibration-free table and covered with a dark cage to minimize interference from stray light. The protease activity was expressed as a change of fluorescence per minute. In each experiment, change in fluorescence of a single fiber cell was recorded for 30 minutes, but in all calculations of the enzyme activity, only the slope of the linear increase in the enzyme activity was used.
Statistical Analysis
All results are expressed as the mean ± SEM. Significance of difference was evaluated using Students t-test. Difference is significant at P < 0.05.
Determination of Enzyme Activity
Calpain.
Calpain activity was determined according to the method of David and Shearer.14
Briefly, the reaction mixture (0.1 mL) contained 60 µL protein fraction, 20 µL fluorescein-casein (5 mg/mL) and 20 µL 20 mM Tris-HCl (pH 7.5), containing 15 mM CaCl2 and 10 mM ß-ME. The reaction mixture was incubated at 25°C for 30 minutes, the reaction was stopped by placing the sample on ice, and 50 µL (12 mg/mL) bovine serum albumin was added, followed by 0.2 mL 10% trichloroacetic acid. After centrifugation at 10,000g for 5 minutes, 100 µL supernatant was removed and added to 100 µL 1.5 M Tris-HCl (pH 8.6). The fluorescence of the samples was determined at 525 nm after excitation at 365 nm, using a plate reader (FluoroCount; Packard Instruments, Meriden, CT). The amount of fluorescein-labeled, acid-soluble fragments was determined by comparison with standards of 0 to 5 µg undegraded fluorescein casein dissolved in 0.5 M Tris-HCl (pH 7.5; assuming that the casein was uniformly labeled by the fluorescein dye). One unit of calpain activity was defined as 1 µg of acid-soluble fragment released from casein per minute. Whenever described, calpain activity was also determined by using leu-p-nitroanilide as a substrate.18
FCGAP.
FCGAP activity was determined by using GSH and BOC-Leu-Met-CMAC. The 2.0-mL reaction mixture contained 10 mM Tris-HCl (pH 8.0), 20 µL 100 mM GSH, 20 µL 1 M CaCl2, 50 to 200 µL protein sample, and 10 µL 2 mM BOC-Leu-Met-CMAC. FCGAP activity was determined at room temperature by noting the increase in fluorescence at an excitation wavelength of 360 nm and measuring emission at 410 nm with a spectrofluorometer (F-4500; Hitachi, Ltd., Tokyo, Japan). One unit of enzyme activity was defined as 1 micromole substrate cleaved per minute.
Protease Purification
Eyeballs from 12 rats were removed in 10 mM Tris-HCl (pH 7.5) containing 1 mM EDTA, 1 mM EGTA, and 10 mM ß-ME (buffer A). Lenses were dissected and the epithelium removed. The remaining lens was homogenized in buffer A with an (Omnimixer; Sorvall, Newtown, CT) to make a 10% homogenate (wt/vol). The homogenate was centrifuged at 10,000g for 30 minutes, and the supernatant was used to determine the protease activity with fluorescein-labeled casein (for calpain) and BOC-Leu-Met-CMAC (for FCGAP), as described earlier. The supernatant was applied to a DEAE gel column (21 x 1 cm), preequilibrated with buffer A at a flow rate of 30 mL/h. The column was washed with the same buffer for 2 hours and eluted by using a 200 mL linear gradient of 0 to 300 mM NaCl in Buffer A.
Immunoprecipitation
For the precipitation of protease activity, appropriate dilutions of antisera, raised against µ- and m-calpain or LAP were incubated with enzyme preparations overnight at 4°C. Subsequently, secondary antibodies raised against mouse or rabbit IgG were added, and the samples were allowed to stand for an additional 4 to 6 hours, followed by centrifugation at 10,000g for 15 minutes. Supernatants were used to determine the calpain and FCGAP activity.
Effect of Protease Inhibitors on the Enzyme Activity
We investigated the effect of protease inhibitors by incubating 200 µL FCGAP fraction and 48 µL calpain fraction separately with 0.05 mM bestatin, and 0.5 mM each leupeptin, antipain, chymostatin, and E-64 for 30 minutes at room temperature (23°C). After incubation, the samples were assayed for FCGAP activity in a total volume of 2.0 mL and for calpain activity in a reaction mixture of 0.1 mL, as described earlier.
Rat Lens Culture
The eyeballs were removed from the rats, and the lenses were dissected in phosphate-buffered saline under sterile conditions, with the aid of a dissecting microscope. Each of the dissected lenses was immersed in a separate well of a 24-well tissue culture plate containing medium 199 supplemented with 1% penicillin-streptomycin. Lenses were divided into four groups, one control and three experimental. Each group had three lenses. The control group lenses (group A) were incubated with medium 199 containing 5.5 mM glucose, and the experimental groups were incubated with medium 199 containing 50 mM glucose (group B), 50 mM glucose+0.05 mM bestatin (group C), and 50 mM glucose+0.05 mM E-64 (group D). The lenses were maintained in a humidified atmosphere of 5% CO2 and 95% air at 37°C, as described previously.19
The incubation medium was changed every 24 hours. The incubations were staggered so that all the lenses, incubated for 0, 3, 6, and 8 days, were ready for biochemical measurements and digital image analysis at the same time under identical conditions.
The opacity of the lenses was examined by digital image analysis, as described elsewhere.19 Briefly, the imaging system consisted of a TV camera (Optronics Engineering, Goletta, GA) attached to the television port of an inverted microscope (Nikon). The condenser was adjusted for Köhler illumination. To view the entire lens, a 2x objective was used. The first series of images were collected under a condition in which the illumination was increased so that the center of the control (untreated) lens (on day 0) saturated the acquisition system. No quantitative information was obtained from these images. For quantitative measurements, the illumination intensity was adjusted so that the maximum transmittance through the control untreated (on day 0) lens, measured by the camera, was just below the saturation threshold of the camera. The illumination remained unchanged for all subsequent measurements, and the images were acquired and analyzed using image-analysis software (Metamorph; Universal Imaging, West Chester, PA). Each lens was placed in a 2.5-cm Petri dish containing phosphate-buffered saline.
Quantitative measurements were made from each lens for each condition measured in triplicate. Each lens was divided into four concentric circular regions by measuring the radius of each lens and dividing it into four equal segments. An annulus, the width of which was equal to one fourth the radius of the lens, was constructed and the average pixel intensity was measured in each region. The average pixel intensity, measured from homologous regions for each of the three lenses for each treatment, was averaged.
Biochemical Measurements
The lenses from all the groups, after the indicated days in culture, were homogenized in 0.5 mL 20 mM potassium phosphate (pH 7.0) by sonication for 30 seconds using a sonifier cell disrupter (model W185 Heat Systems; Ultrasonics Inc., Plainview, NY). For measuring GSH, 0.2 mL homogenate was mixed with 0.3 mL precipitating reagent (0.2 M glacial meta-phosphoric acid, 5.1 M NaCl and 5.9 mM EDTA). After centrifugation at 10,000g for 15 minutes, 0.2 mL supernatant was added to 0.8 mL 0.3 M Na2HPO4, followed by the addition of 0.1 mL 5,5' dithiobis (2-nitrobenzoic acid; DTNB; 0.04% in 1% sodium citrate). The change in optical density (OD) at 412 nm was recorded using a spectrophotometer (UV-Vis; Varian, Sunnyvale, CA), as described previously.19
Soluble and insoluble proteins were determined by the Bradford method,20
using 5 µL aliquots of homogenate before and after centrifugation at 10,000g for 15 minutes. For measuring sorbitol, the homogenate was ultrafiltered (YM10 Centricon; Millipore, Bedford, MA). An aliquot of the filtrate was lyophilized in a Savant Asigo Automatic Speed Vac (Farmingdale, NY) until completely dry and stored overnight in a vacuum desiccator containing calcium chloride as the desiccant. The samples were derivatized by adding 0.1 mL of a solvent (Deriva-sil) under anhydrous conditions. The derivatized mixture (1 µL) was injected into a gas chromatography (GC) system (model 3400; Varian). The temperature gradient was set to increase from 140°C to 170°C at 4°C/min and from 170°C to 250°C at 50°C/min. The amount of sorbitol present in a sample was calculated using reagent sorbitol measured by GC under similar conditions. Aldose reductase (AR) activity was determined by using an aliquot of 10,000g supernatant and glyceraldehyde, as described elsewhere.21
| Results |
|---|
|
|
|---|
|
|
|
Immunologic Nature of FCGAP, Calpain, and LAP.
Our results show that FCGAP is immunologically distinct from calpain and LAP, because the FCGAP in the unadsorbed fraction of the DEAE gel column was not precipitated by antibodies against LAP, m-calpain, or µ-calpain (data not given). By comparison, the antibodies against calpain precipitated more than 75% of the calpain activity from the calpain fraction as well as the commercial calpain. Similarly, antibodies against LAP precipitated the commercially procured LAP but did not precipitate calpain or the FCGAP activity.
Inhibition of FCGAP and Calpain by Protease Inhibitors.
We used several protease inhibitors to inhibit FCGAP and calpain. Leupeptin, chymostatin, antipain, and E-64 significantly (60%90%) inhibited the activity of the calpain fraction and the commercial calpain, but did not inhibit (<3%) FCGAP activity (Table 1) . In contrast, 0.05 mM of the aminopeptidase inhibitor bestatin inhibited FCGAP by more than 80%, but had little or no effect on calpain activity. Thus, based on the effects of protease inhibitors, FCGAP appears to be distinct from calpain. These results indicate that even at low [Ca2+]i, some Ca2+-activated protease activity in the fiber cells increases, which activates the FCGAP that may be responsible for the globulization of fiber cells as well as cataractogenesis. Therefore, we examined the effect of bestatin, a FCGAP inhibitor, on the globulization of isolated fiber cells and also on glucose-induced opacification of rat lens in culture.
|
Prevention of Glucose-Induced Lens Opacification by Bestatin and E-64.
As shown in Figure 4
, digital image analysis of control and treated rat lenses clearly illustrates the increase in lens opacity in the presence of high (50 mM) glucose and the protective effect of the protease inhibitors bestatin and E-64. Figure 4 (left) shows images of the lenses with the light adjusted so that the central portion of the day 0 control lens saturated the camera. Under these light conditions, the differences in the effect of the treatment, although visually apparent, do not allow accurate quantification. Therefore, for quantification (Fig. 4
, right), the light intensity was adjusted so that the camera was just below saturation for the day 0 control lens. Each row illustrates a lens representative of each treatment as indicated in the figure legend. Both bestatin (row C) and E-64 (row D) were effective in preventing the lens opacification compared with glucose alone (row B).
|
|
Biochemical Changes in Lenses Cultured with High Glucose and Protease Inhibitors
Biochemical changes on various days of lens culture are given in Table 2
. In the lenses of all the groups, there was no significant change in the ratio of soluble to insoluble proteins and GSH on day 3, but AR activity dropped by more than 50% in the lenses cultured in 50 mM glucose compared with the lenses incubated with 5.5 mM glucose. Bestatin and E-64 provided significant protection against the 50 mM glucose-induced change in AR activity. The sorbitol levels in the 50-mM glucose group increased by twofold compared with those in the 5.5-mM glucose group, whereas in the 50-mM glucose+bestatin and 50-mM glucose+E-64 groups, the sorbitol levels increased 50- and 37-fold, respectively. On days 6 and 8, GSH levels and the ratio of soluble to insoluble proteins in the lenses of the 50-mM glucose group decreased by 50% to 60%, compared with the control (5.5 mM glucose). On days 6 and 8, there was no significant change in the ratio of soluble to insoluble proteins and GSH between the lenses of the control group and those of the 50-mM glucose+bestatin or 50-mM glucose+E-64 groups, indicating that these protease inhibitors provide a significant protection against glucose-induced biochemical changes in the lens. Similarly, the sorbitol levels were considerably higher in the 50-mM glucose+bestatin and 50-mM glucose+E-64 groups on days 6 and 8, compared with the control and 50-mM glucose groups.
|
| Discussion |
|---|
|
|
|---|
Partial purification of proteases from rat lens cortex by using DEAE-gel chromatography, according to the method of David and Shearer,14 separated the calpain and the FCGAP. The FCGAP did not bind to the column, whereas calpain bound to the column and was eluted at approximately 180 mM NaCl. Fluorescein-labeled casein, generally used as a substrate for assaying calpain activity, was cleaved by the calpain fraction but not by the unadsorbed fraction that contained the FCGAP activity. Similarly, BOC-Leu-Met-CMAC was cleaved by unadsorbed FCGAP fraction but not by the calpain fraction. However, the BOC-Leu-Met-CMAC is a substrate of calpain in an intact cell. This substrate conjugates with GSH, and the membrane is not permeable to the complex. The proteases cleave the conjugate to form a fluorescent compound CMAC-SG. Because the unadsorbed fraction of the DEAE gel column contained glutathione S-transferase activity also, it probably conjugates the BOC-Leu-Met-CMAC to GSH, which is the substrate for FCGAP and probably also for calpain in an intact fiber cell. Therefore, the use of BOC-Leu-Met-CMAC as a substrate to determine intracellular protease activity has led investigators to assign this activity to calpain. Significantly, in our experiments the FCGAP (DEAE-gel column unadsorbed) did not require calcium for activation. Thus, in a cascade of events, increased [Ca2+]i may activate a protease that could activate FCGAP directly or through other protease(s). The activation could be due to the cleavage of the FCGAP precursor or a proteinaceous ligand (inhibitor) bound to the enzyme similar to calpastatin. This possibility is supported by a twofold activation of FCGAP activity when the FCGAP and calpain fractions were incubated together in 2 x 10-3 M Ca2+. Nonetheless, the possibility that calpain or any other protein in the calpain fraction behaves like calmodulins and delivers Ca2+ to FCGAP cannot be completely ruled out. Further investigation is needed to delineate this pathway(s), which is downstream to the Ca2+-activated protease(s).
Cysteine protease inhibitors, such as leupeptin, pepstatin, and E-64 inhibited calpain activity,12 13 but did not significantly inhibit FCGAP activity. FCGAP was inhibited, however, by more than 80% by the aminopeptidase inhibitor bestatin, whereas this inhibitor did not inhibit calpain. We therefore, reasoned that bestatin should be able to prevent or significantly delay the globulization of isolated rat lens cortex fiber cells. Our results show that, indeed, bestatin prevented globulization of fiber cells when incubated in Ringers solution containing 2 x 10-3 M Ca2+ for more than 4 hours. This was the best protection that we have observed so far by any protease inhibitor or calcium chelator. These interesting observations prompted us to investigate whether bestatin could prevent or significantly delay cataract in rat lenses cultured in high glucose.
Digital image analyses of rat lenses, cultured in 50 mM glucose for up to 8 days, showed that the lenses had progressive development of more than 80% opacity in the nuclear region (Fig. 5A) in 8 days, as determined by transmittance measurements.19 In contrast, the group of lenses cultured in 50 mM glucose+0.05 mM bestatin, had approximately 50% opacity, which was only slightly greater than the control lenses cultured in 5.5 mM glucose, which had approximately 40% opacity, indicating excellent protection from hyperglycemic cataractogenesis by bestatin. The calpain inhibitor, E-64 also prevented the opacification of lenses cultured in 50 mM glucose, as described by Nakamura et al.12 and Shearer et al.,13 except that bestatin provided significantly better protection against opacification in the nuclear region. The biochemical determinations such as ratio of soluble-insoluble proteins and GSH also substantiated the protective effect of bestatin. Sorbitol and aldose reductase levels were unexpectedly more than an order of magnitude higher in the 50-mM glucose+bestatin and E-64 groups compared with 50 mM glucose alone, indicating that osmotic changes due to sorbitol accumulation are not the main cause of lens opacification in high glucose. These results are similar to those we have published earlier demonstrating the protection of hyperglycemia-induced cataractogenesis by antioxidants such as butylated hydroxytoluene (BHT) and Trolox (Hoffman LaRoche, Nutley, NJ).23 24 This suggests that preservation of the structure of the lens maintains high AR activity, and that sorbitol levels and cataract formation may not be causally related.
Based on these observations, we propose the sequence of events that cause hyperglycemia-induced lens opacification to be enhancement of calcium influx, which in turn activates the FCGAP(s). The activated protease(s) cleaves cytoskeletal and membrane proteins that form the substratum for the elaboration of light-scattering centers and the development of cataract.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication September 28, 2001; revised February 4, 2002; accepted March 1, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Satish K. Srivastava, Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, 6.644 Basic Science Building, Galveston, Texas 77555-0647; ssrivast{at}utmb.edu.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Chaerkady and K. K. Sharma Characterization of a Bradykinin-Hydrolyzing Protease from the Bovine Lens Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1214 - 1223. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |